The neurological safety of epidural pamidronate in rats
- PMID: 20556213
- PMCID: PMC2886240
- DOI: 10.3344/kjp.2010.23.2.116
The neurological safety of epidural pamidronate in rats
Abstract
Background: Pamidronate is a potent inhibitor of osteoclast-mediated bone resorption. Recently, the drug has been known to relieve bone pain. We hypothesized that direct epidural administration of pamidronate could have various advantages over oral administration with respect to dosage, side effects, and efficacy. Therefore, we evaluated the neuronal safety of epidurally-administered pamidronate.
Methods: Twenty-seven rats weighing 250-350 g were equally divided into 3 groups. Each group received an epidural administration with either 0.3 ml (3.75 mg) of pamidronate (group P), 0.3 ml of 40% alcohol (group A), or 0.3 ml of normal saline (group N). A Pinch-toe test, motor function evaluation, and histopathologic examination of the spinal cord to detect conditions such as chromatolysis, meningeal inflammation, and neuritis, were performed on the 2nd, 7th, and 21st day following administration of each drug.
Results: All rats in group A showed an abnormal response to the pinch-toe test and decreased motor function during the entire evaluation period. Abnormal histopathologic findings, including neuritis and meningeal inflammation were observed only in group A rats. Rats in group P, with the exception of 1, and group N showed no significant sensory/motor dysfunction over a 3-week observation period. No histopathologic changes were observed in groups P and N.
Conclusions: Direct epidural injection of pamidronate (about 12.5 mg/kg) showed no neurotoxic evidence in terms of sensory/motor function evaluation and histopathologic examination.
Keywords: epidural injection; neurotoxicity; pamidronate.
Figures


Similar articles
-
Evaluation of the neurological safety of epidurally-administered pregabalin in rats.Korean J Anesthesiol. 2012 Jan;62(1):57-65. doi: 10.4097/kjae.2012.62.1.57. Epub 2012 Jan 25. Korean J Anesthesiol. 2012. PMID: 22323956 Free PMC article.
-
The neurological safety of epidural parecoxib in rats.Neurotoxicology. 2011 Dec;32(6):864-70. doi: 10.1016/j.neuro.2011.05.011. Epub 2011 Jun 6. Neurotoxicology. 2011. PMID: 21669221
-
The neurological safety of epidural gabapentin in rats: a light microscopic examination.Anesth Analg. 2005 Nov;101(5):1422-1426. doi: 10.1213/01.ANE.0000180197.32577.9B. Anesth Analg. 2005. PMID: 16244005
-
Bisphosphonates and breast carcinoma.Cancer. 1997 Oct 15;80(8 Suppl):1668-73. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1668::aid-cncr17>3.3.co;2-5. Cancer. 1997. PMID: 9362434 Review.
-
Bisphosphonates for cancer patients: why, how, and when?Support Care Cancer. 2002 Jul;10(5):399-407. doi: 10.1007/s005200100292. Epub 2001 Oct 19. Support Care Cancer. 2002. PMID: 12136223 Review.
Cited by
-
Relationship between bone mineral density and the frequent administration of epidural steroid injections in postmenopausal women with low back pain.Pain Res Manag. 2014 Jan-Feb;19(1):30-4. doi: 10.1155/2014/870145. Epub 2014 Jan 8. Pain Res Manag. 2014. PMID: 24404559 Free PMC article.
References
-
- Gangji V, Appelboom T. Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. Clin Rheumatol. 1999;18:266–267. - PubMed
-
- Reid IR. Bisphosphonates: new indications and methods of administration. Curr Opin Rheumatol. 2003;15:458–463. - PubMed
-
- Bonabello A, Galmozzi MR, Bruzzese T, Zara GP. Analgesic effect of bisphosphonates in mice. Pain. 2001;91:269–275. - PubMed
-
- Bonabello A, Galmozzi MR, Canaparo R, Serpe L, Zara GP. Long-term analgesic effect of clodronate in rodents. Bone. 2003;33:567–574. - PubMed
-
- Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain. 2000;88:239–248. - PubMed
LinkOut - more resources
Full Text Sources